英派药业致力于研发具有自主知识产权的靶向抗癌创新药，专注于合成致死作用机制。公司以DNA损伤修复通路（DDR）自主研发产品为基础，构建了全球生物医药公司中覆盖面最广的DDR产品组合之一，并且正在逐步拓展到更多的全新的合成致死靶点。
Company Details
- Employees
- 26
- Founded
- 2009
- Address
- 上海浦东新区三林镇街道, 海阳西路399号前滩时代广场,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Henlius USA Inc..
- HQ
- 上海
Impact Therapeutics 英派药业 Questions
Impact Therapeutics 英派药业's website is http://www.impacttherapeutics.com
Impact Therapeutics 英派药业's LinkedIn profile is https://cn.linkedin.com/company/impact-therapeutics
Impact Therapeutics 英派药业 has
26 employees.
View email and phone details for 26
employees at Impact Therapeutics 英派药业.
Impact Therapeutics 英派药业's industry is
Pharmaceutical Manufacturing
Impact Therapeutics 英派药业's top competitors are
Denali Therapeutics,
Budscout Ai, Inc.,
上海挚盟医药科技有限公司,
Innarx,
Henlius Usa Inc.,
Lilly Asia Ventures 礼来亚洲基金,
追什麼運動有限公司,
Simon-Kucher,
Self Employed,
Beone Medical Affairs.
Impact Therapeutics 英派药业's categories are Pharmaceutical Manufacturing
Impact Therapeutics 英派药业's founding year is 2009
